North Dakota
How Association for Molecular Pathology v. Myriad Genetics, Inc. applies in North Dakota: state-specific rules, key cases, and bar exam notes for Intellectual Property (Patent Law).
North Dakota law parallels federal standards in patentability, particularly concerning the non-patentability of abstract ideas and natural phenomena. The state maintains a strict adherence to the principles set forth in the Myriad case relating to isolated genes.
In North Dakota, as established through recent jury instructions and legal interpretations, laws governing patent eligibility require that a claimed invention must be more than a mere discovery of a natural phenomenon, thus aligning with the precedent set in the Myriad case.
The court affirmed that merely isolating a naturally occurring substance does not fulfill the requirements of patentable subject matter.
The ruling reinforced that utility patents must present a novel application beyond what is naturally occurring.
The decision emphasized strict requirements for demonstrating the novelty of innovations that build upon natural phenomena.
North Dakota courts apply the federal standard articulated in Myriad, which disallows patents on naturally occurring substances without any transformative application. The emphasis in both jurisdictions remains on achieving concrete and non-abstract inventions, rejecting patents that claim natural phenomena as their foundational basis.
Understanding the rulings in Myriad is crucial for North Dakota bar examinees, particularly in essay questions involving patent eligibility assessments.